By Nigel Praities
NICE has recommended liraglutide as a treatment for some patients with type 2 diabetes who are not controlled adequately on two diabetes treatments.
Their final appraisal determination says liraglutide 1.2 mg should only be used in combination with two other therapies - metformin and a sulfonylurea, or metformin and a thiazolidinedione - when control of blood glucose remains inadequate, and the person is severely obese with psychological or medical problems associated with high body weight, or insulin therapy is not appropriate.
Pulse October survey
Take our July 2025 survey to potentially win £1.000 worth of tokens
